Doppler ultrasound as a screen for hepatic artery thrombosis after liver transplantation. by Segel, MC et al.
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2 Mean scon's for prognostic indices (range 0--2 I J J) in 17 1'108 [.£ . biopsies of 22 grafts with resistant rejection 
Mean score (±SD) 
1982-83: (0) 1983-8-4: (+ cyclosp0nne [7]) 
~r*f!DffDDD 1.6±0.7 1.4±O.8 · .' i >nudesT infiil rale 
" on, . O.4±O.i 0.3±0.5 ~e<llal necrosIs 
• ," ::iC~yg1 i 0.2±O.5 0 
· Thr(lm\""IS . 
Endothelial swelling 1.1±O.6 0.9±O.7 
JaU'rstit ial he~orrhage 0.7±0.3 0.8 
'fllbult'S:necrosls 0.1 0 
:.----
infiltrate, and there was no difference between the prognostic 
,cores (Table 2). 
These findings suggest that acute vascular rejection not 
ntrolled by conventional immunosuppression may respond, 
co some cadaver graft recipients, to introduction of cycIospor-
::e. Vascular rejection has not previously been shown to im-
rove with cyclosporine used as a secondary immunosuppres-~ntKlther studies supporting its efficacy have shown variable 
benefit, without assessment of graft histology (9. ]0, 12. ]3). 
This suggests that some of the advantages of cycIosporine may 
be achieved by those preferring to use azathioprine and pred-
nisolone as initial immunosuppression. CycIosporine may com-
plement the role of conventional therapy for treatment of acute 
vascular rejection. 
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DOPPLER ULTRASOUND AS A SCREEN FOR HEPATIC ARTERY THROMBOSIS AITER LIVER 
TRANSPLANTATION 
Doppler ultrasound combined with real-time ultrasound al-
low~ evaluation of both the hepatic art.ery and hepatic paren-
ch.,·ma after liver transplantation. Hepatic artery thrombosis 
following liver transplantation is a devastating event that may 
requirl? emergency retransplant-at ion. Unfortunately, clinical 
iiiI'm are often nonspecific. Results of angiographic evaluation 
for clinically suspected hepatic artery thrombosis have been 
normal in 76'IC of patients at our institution. 
In a prospective study utilizing pulsed Doppler and real-time 
ultrasound, 29 transplant patients were examined. Six tram'-
plant~ had no hepatic artery Doppler pulse. All six had abnor-
mal angiograms: four had hepatic artery thrombosis, one had a 
~f!mificant anastomotic stenosis, and one had slow flow with 
hiops~D-proved ischemia. Of 23 patients with a Doppler pulse. 
two had surgicaJJy proved hepatic artery thrombosis. However, 
both had a focal abscess in the liver by real-time ultrasound. 
There were no cases of hepatic artery thrombosis in 21 patients 
with both a normal Dappler hepatic artery pulse and normal 
liver parenchyma. 
Our data demonstrate that a combination of hepatic artery 
Doppler ultrasound and anatomical imaging of the liver cur-
rently is the optimal screening test for selecting which patients 
need hepatic angiography following liver transplantation. 
Doppler ultrasound (pulsed Doppler imaging combined with 
real-time ultrasound) is an exciting new radiographic imaging 
modality available to physicians involved in liver and renal 
transplantation (1-3). This duplex imaging device detects 
blood flow via the ao~pler shift from a single selected vessel 
localized by real-time ultrasound. Thus. noninvasive detection 
of arterial and venom blood flow to and from the allograft 
organ i~ now possible. 
Hepatic artery thrombosis following liver transplantation 
usually occurs within the first three postoperative months and 
is a devastating event that, in the majority of patients, requires 
540 
TABLE 1. Comparison of Doppler and real-timf' ultrasound (RTU) 
findings with th .. incidence of hepatic artery lhrombosi~ after liver 
tramplantat ion 
~ormal Doppler, normal RTll 
~prm:ll DUPl'ln, ahnormal RTt ',c 
Abnormal Doppler,' normal RTl' 
Abnormal Doppler,' abnormal RTU· 
~ilmhtDr ot HqHHi{ er1tDr~ 
tr&ll:!.plant:.. thromhosif. 
21 None' 
• Abnormal RTU = foc.al hepatic abscess or infarct. 
b Abnormal Doppler = absent hepatic artery flow, 
'Three by angiography, eighteen by clinical follow-up, 
d In the other two patients, both had patent but abnormal hepatic 
arteries. In one, a severe anastomotic stenosis was present, and the 
other showed markedly reduced flow with biopsy-proved ischemia, 
immediate therapeutic intervention. The patient may develop 
fever and elevated liver enzymes, especially serum transami-
nases_ If hepatic infarction develops, infection often super-
venes, Finally, toxic septicemia results from septic hepatic 
gangrene (4. 5), Emergency hepatic retransplantation is the 
patient's only hope for survival (6)_ 
Angiography, an invasive examination, has been the defini-
.tive procedure to evaluate patency of the hepatic artery follow-
ing liver transplantation (7). On the basis of clinical criteria 
alone, one cannot effectively predict which transplant patient 
needs an arteriogram, 
From January 1981 to October 1984, prior to the availability 
of Doppler ultrasound, 33 angiographic studies (18 children, 15 
adults) were performed at the University Health Center of 
Pittsburgh for the clinical suspicion of hepatic artery throm-
bosis aft~r liver transplantation_ Of these, 61 % (11/18) of the 
children and 93% (14/15) of the adults had patent hepatic 
arteries_ 
Currently. we use three noninvasive imaging modalities to 
evaluate the liver after transplantation: computed tomography 
(CT),* real-time ultrasound, and Doppler ultrasound_ CT and 
real-time ultrasound are useful for evaluating the liver paren-
chyma to detect focal areas of infarction and/or abscess. How-
ever, only Doppler ultrasound can detect flow within the allo-
graft hepatic artery_ 
The purpose of this communication is to demonstrate the 
immense value of noninvasive imaging as a screen for angiog-
raphy in liver transplant patients with suspected hepatic artery 
thrombosis. In our institution, the allograft liver parenchyma 
is imaged with real-time ultrasound when the patency of hepatic 
artery is evaluated with pulsed Doppler ultrasound. If ultrasonic 
visualization of the liver parenchyma is unsatisfactory or equiv-
ocal then CT of the liver may be performed without and with 
intravenous contrast material. 
During the 51 month period from January 1981 to April 1985, 
330 patients (147 children, 183 adults) received 435 orthotopic 
liver transplants at the l 'niversity Health Center of Pittsburgh_ 
Seventy-seven patients received two transplants each and 14 
patients recei\'ed three transplants each, There were 150 male 
and 180 female patients with an ag~ range from 4 months to 
57 years. 
During this time 42 angiographi(' studies (25 in children, 17 
in adults) were performed for evaluation of hepatic artery 
paten('y after liver transplantation. This includes the initial 33 
pat ients eval ual ed prior to Doppler and 9 additional patients 
• Abbreviation used: CT, computed tomography. 
B 
FIGlRE L Normal Doppler ultrasound findings. (A) position of 
cursor line through hepatic artery (straight arro",) on sagittal view for 
Doppler waveform shown in (B). Portal vein (curved arrow); (B) normal 
Doppler hepatic artery waveform_ 
studied since Doppler ultrasound became available_ In all cases. 
angiography was performed within the first two months follow-
ing her transplantation. 
Between October 1984 and April 1985, pulsed Doppler and 
real-time ultrasound examinations have been performed on 28 
liver transplants to evaluate hepatic artery patency and the 
liver parenchyma_ Eighteen have been followed clinically with-
out angiography_ ~ine transplants underwent angiography and 
two had emergenc:.- surgery without angiography_ 
Doppler and real-time ultrasound imaging were perf0rmec 
on 29 transplanted livers. A comparison of the Doppler anrl 
real-time ultrasound firJdings with the incidence of hepatic 
artery thrombosis is sbown in Table L In 23 transplants. 
Doppler ultrasound demonstrated arterial flow to the liver (Fig. 
1 L Three patients underwent angiography that demonstrated 
patent hepatic arteries in each case. In twenty transplants. 
angiography was not performed, based on the normal Doppler 
study. In two of the twenty transplants, a focal abscess wa;; 
identified in the liver by real-time ultrasound_ Because of 
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I· 'cal deterioration, bot h pat ients required emergency re-e In l ..
splantation. Both had hepatic artery thrombosIs. Of the tra~aining eighteen, none havt developed hepatic artery throm-
f~nK_ Four have required retransplantation for reason~ other KKKKKI~f:" . 
. ,. IWIlatic i1rltDr~ thrElmzIo~j~K Two patients died, ont uj grail 
ll"lll 
r ilure and one of cardiac arrest. 
/I In six transplants, no e\idence of hepatic arterial flow was 
knt ified in tht liHr hilum b\ Doppltr imaging. AllgiE>graph~ 
~DaI abnormal in all six ca~esK Four had hepatic artery throm-
bosis- In one of the four, angiography also revealed arterial 
collaterals to the transplanted liver while a small infarct was. 
~n on ultrasound. In the fifth transplant, a severe steriosis 
... as found at the hepatic artery anastomosis. In the sixth 
transplant, the hepatic arterial tree was narrowed with mark-
tdl\' reduced washout of contrast within the liver, suggesting 
.. lo~· flow. Liver biopsy showed changes consistent with ische-
mia. 
Hepatic artery thrombosis following liver transplantation 
~hould be suspected if there is a focal hepatic abscess/infarct, 
~r if there is absence of blood flow by Doppler examination in 
lhe hepatic artery within the porta hepatis. In the six trans-
plants with abstnt Doppler findings of hepatic artery flow, all 
had abnormal angiograms_ Of 14 patients with focal alterations 
(abscess/infarct) in the liver by CT and/or ultrasound from 
1982 to 1985,86% (12/14) have had hepatic artery thrombosis 
(3). 
Doppler ultrasound imaging of the hepatic artery is the only 
currently available noninvasive method for detecting hepatic 
artery thrombosis before infarction occurs. In one patient, a 
liingle day of fever prompted a Doppler ultrasound examination 
that detected no evidence of arterial flow; angiography revealed 
hepatic artery occlusion. The patient was retransplanted the 
Ii8me day. Pathology of the liver revealed no evidence of hepatic 
infarction, even though hepatic artery thrombosis was present. 
Doppler ultrasound imaging of the hepatic artery, together 
with real·time ultrasound examination of liver parenchyma, 
should be the initial test in patients suspect~d of having hepatic 
artery thrombosis after liver transplantation. CT may give 
complimentary information in difficult or equivocal cases. In 
experienced hands, Doppler confirmation of hepatic arterial 
flow with normal liver parenchyma on real-time ultrasound 
obviates angiography. Abse~Ice ~ hepatic artery flow in the 
porta hepatis by Doppler imaging or the presence of a focal 
hepatic abscess or infarct by real·time ultrasound or CT war-
rant~ immediate angiography. 
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C'YCLOSPORINE-ASSOCIATED MICROANGIOPATHY IN RENAL TRANSPLANTATION: A SEYERE BUT 
POTENTIALLY REVERSIBLE FORM OF EARLY GRAFT INJURY 
Cyclosporine (CsA)* is a fungal metabolite that has been 
shown to have immunosuppressive properties, presumably 
through modulation of T lymphocyte activity (1-3). Thtse 
pruperties haH made CsA a clinically useful drug in suppressin;r 
rtJtction of transplanted bone marrow (4), kidney 15-71. liver 
(7. 8), and heart/lung (9). However, several important sidt· 
eflects of C'sA such as renal toxicity (10)' hepatic injury (l(;-
II '. and h:-1wrtension (13, J.1 ) have been found to inttrfere 
• Abbreviations used: esA, C'ycJosporine; D\'AH, Durham Veterans-
Administration Hospitsl: HllS, hemolytic-uTl'mic syndrome: PRA. per· 
': t'nldge of ~anel-reacliyD{D antibod~·K 
wit h the drug's usefulness. One complication that ha~ been well 
documtnted in bont marrow transplant recipients given CsA is 
a condition similar to hemol~Dtic·memic svncirome (HlJS1, man-
ifeqed by awtemia, anemia with red blood cell fragmentation, 
hypertension, thrombocy'topenia, and glomerular capillary 
thromboses (15-17). This complication ofC'sA has n')t yet been 
repnrttd as arising de novo in renal transpla:1t recipients. 
perhaps because of the clinical and histopat hological similari-
ties to acute humoral·vascular rejection. \\'e here describe a 
case of thrombotic microangiopathy and glomerulopathy in a 
renal allograft associated with C'sA use, with rapid resolut ion 
upon withdrawal of the drug. This is a particularly important 
